Organ trafficking and transplant tourism
Organ trafficking and transplant tourism are the illicit trade in organs and travel for commercial transplantation; the global response centers on the Declaration of Istanbul.
Organ trafficking and transplant tourism are interrelated illicit practices in which human organs are obtained, transferred, or transplanted through coercion, exploitation, or commercial sale, typically at the expense of poor and vulnerable people.[1][2] They are condemned by the leading international instruments in the field, the Declaration of Istanbul, the World Health Organization Guiding Principles, and the Council of Europe Convention against Trafficking in Human Organs, and are prohibited under the domestic law of many countries, including the United States, where the National Organ Transplant Act (NOTA) criminalizes the transfer of organs for valuable consideration.[2][3]
Definitions
The most widely adopted definitions are those of the 2018 Declaration of Istanbul, which align with the Council of Europe Convention (2015) and the United Nations Palermo Protocol (2000):[1]
- Organ trafficking comprises removing organs without valid consent or in exchange for financial gain; transporting, manipulating, or transplanting such organs; offering or requesting undue advantage to facilitate these acts; soliciting or recruiting donors or recipients for financial gain; and attempting, aiding, or abetting any of these.[1]
- Trafficking in persons for the purpose of organ removal is the recruitment, transport, harbouring, or receipt of persons by coercion, fraud, deception, or abuse of a position of vulnerability, for the purpose of removing their organs.[1]
- Transplant commercialism is a policy or practice in which an organ is treated as a commodity to be bought, sold, or used for material gain.[1][2]
- Travel for transplantation is the movement of persons across jurisdictional borders for transplantation. It becomes transplant tourism, and thus unethical, when it involves trafficking in persons or organs, or when resources devoted to non-resident patients undermine a country's ability to serve its own population.[1]
The Declaration's distinction between (legitimate) travel for transplantation and (illegitimate) transplant tourism is important: a patient who travels abroad for a transplant through a lawful, reciprocal, and non-exploitative arrangement is not engaged in transplant tourism, whereas one who travels to purchase an organ from a paid living seller is.[1]
Scale and patterns
A frequently cited 2007 estimate, associated with the World Health Organization and incorporated into the Declaration of Istanbul, held that up to 10% of organ transplants worldwide involved trafficking or commercialism.[1][4] More recent law-enforcement and academic assessments treat such figures as inherently uncertain, given the clandestine nature of the trade, but agree that the practice is persistent and global.[5]
The dominant pattern is the international commercial kidney trade: recipients from wealthier countries travel to a country with weak regulation to receive a kidney from a paid living "donor" who is, in fact, a seller.[2][6] Historically, the principal destination countries for commercial transplants have included the Philippines, India, and Pakistan, among others, with corridors shifting over time as countries tighten or relax enforcement.[6][7] Sellers are characteristically poor: in studies from India, Pakistan, and the Philippines, most sellers received less than US$2,000 for a kidney, while recipients were often charged more than US$80,000, with the difference captured by brokers, surgeons, and intermediaries.[2]
Drivers
The principal driver is the persistent shortage of transplantable organs relative to demand, which creates a population of patients willing to seek organs outside legitimate channels.[2][6] On the supply side, poverty and debt make selling an organ a desperate option for vulnerable people; organized crime networks, brokers, and complicit medical professionals connect the two.[2][5] Weak regulation, limited deceased-donation infrastructure, and inadequate enforcement in some jurisdictions allow the trade to operate.[1][5]
Health outcomes
Both buyers and sellers fare poorly relative to recipients of regulated, ethically sourced transplants.
For recipients, commercial transplant tourism is associated with worse outcomes due to inadequate donor screening, substandard surgical care, poor wound management, and improper immunosuppression.[8] Returning recipients have been documented to acquire transmitted infections including HIV, hepatitis B and C, cytomegalovirus, tuberculosis, and malaria; one study of patients transplanted commercially in Pakistan found a high prevalence of hepatitis B/C positivity and substantial rates of post-operative complications and death on follow-up.[6][8]
For sellers, the harms are physical, psychological, and economic. Sellers are exposed to coercive brokers, predatory creditors, and physicians indifferent to their welfare, often receive little post-operative care, and frequently see no lasting economic benefit: in one widely cited study, the great majority of kidney sellers who had sold to repay debt reported no improvement in their financial situation afterward.[2]
International legal response
A layered framework has developed to combat these practices:
- The WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation (endorsed in World Health Assembly Resolution WHA63.22, 2010) prohibit payment for organs and call for transparent, equitable, regulated transplantation systems.[4]
- The Declaration of Istanbul (2008, updated 2018) provides the field's professional consensus definitions and principles, calling for the prohibition and criminalization of organ trafficking, financial neutrality, and national self-sufficiency.[1]
- The Council of Europe Convention against Trafficking in Human Organs (CETS No. 216), opened for signature in Santiago de Compostela on 25 March 2015 and in force since 3 March 2018, is the first international criminal-law treaty specifically addressing organ trafficking. It requires states to criminalize the illicit removal of organs (removal without free, informed, and specific consent, or for financial gain) and related solicitation, recruitment, and brokering, and to protect victims; it is open to accession by states worldwide.[3]
- The United Nations Palermo Protocol (2000) covers trafficking in persons for organ removal, and UN General Assembly Resolution 71/322 (2017) addresses organ trafficking specifically.[1]
- National laws, including U.S. NOTA's prohibition on transfer of organs for valuable consideration, criminalize organ sale and trafficking domestically.[1]
Enforcement challenges
Prosecution is difficult. The trade is clandestine and transnational; victims (both sellers and trafficked persons) are often reluctant or unable to come forward; medical professionals may be complicit or unwilling to report suspicions; and jurisdictional fragmentation complicates investigation. Analyses of the small number of prosecuted cases emphasize the need for cross-border cooperation, the criminalization frameworks supplied by the Council of Europe Convention, and the engagement of transplant professionals in detection and reporting.[5]
The China organ-sourcing controversy
A distinct and contested set of allegations concerns the sourcing of transplant organs in the People's Republic of China. Human-rights researchers and several non-governmental bodies have alleged that organs have been forcibly harvested from prisoners of conscience.[9] An independent, non-governmental body styled the "China Tribunal," chaired by a British barrister and reporting in 2019, concluded that forced organ harvesting had been committed "for years throughout China on a significant scale," and identified practitioners of Falun Gong as, in its assessment, the principal source, with concern also expressed about Uyghurs.[9] The Government of China has repeatedly denied these allegations and has stated that it stopped using organs from executed prisoners in 2015 and transitioned to a voluntary citizen-donation system.[9] These claims are the subject of ongoing international scrutiny and dispute; the encyclopedia reports the allegations and the denial without adjudicating them, and notes that the China Tribunal was a privately convened body, not a court or an organ of the United Nations.[9]
See also
- Declaration of Istanbul
- Financial neutrality and the prohibition on valuable consideration
- National Organ Transplant Act (NOTA)
- Living donation
References
- The Declaration of Istanbul on Organ Trafficking and Transplant Tourism (2018 Edition). Definitions and Principles. https://www.declarationofistanbul.org/images/Policy_Documents/2018_Ed_Do/2018_Edition_of_the_Declaration_of_Istanbul_Final.pdf
- The declaration of Istanbul on organ trafficking and transplant tourism. PMC2813140. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813140/
- Council of Europe. Convention against Trafficking in Human Organs (CETS No. 216), Santiago de Compostela, 25 March 2015 (in force 3 March 2018). https://www.coe.int/en/web/trafficking-human-organs/the-convention
- World Health Organization. WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation (WHA63.22, 21 May 2010). https://apps.who.int/gb/ebwha/pdf_files/wha63/a63_r22-en.pdf
- INTERPOL. Trafficking of Human Beings for the purpose of Organ Removal, Analytical Report (2021); and UNODC, Understanding Human Trafficking for Organ Removal (2024). https://www.interpol.int/content/download/16690/file/2021%2009%2027%20THBOR%20ENGLISH%20Public%20Version%20FINAL.pdf
- The outcome of commercial kidney transplant tourism in Pakistan. PubMed 20626425. https://pubmed.ncbi.nlm.nih.gov/20626425/
- Organ Trafficking and Transplant Tourism: A Commentary on the Global Realities. Am J Transplant. https://www.amjtransplant.org/article/S1600-6135(22)05825-7/fulltext
- Transplant tourism increases health-related risks for organ recipients. (research summary). https://www.sciencedaily.com/releases/2015/11/151106132918.htm
- Independent Tribunal into Forced Organ Harvesting from Prisoners of Conscience in China ("China Tribunal"), Summary Judgment, 17 June 2019; and contemporaneous reporting. https://chinatribunal.com/wp-content/uploads/2019/07/ChinaTribunal_-SummaryJudgment_17June2019.pdf
This article is an educational reference for the donation and transplant workforce and the public. It is not medical advice, and it does not replace institutional policy, OPTN policy, or clinical judgment.
See something out of date? Suggest a revision in the Meira app.